Dec 16, 2025 06:03AM
Aug 4, 2025 05:16PM
Apr 16, 2025 02:13PM
Apr 16, 2025 02:12PM
Jan 21, 2025 07:01AM
Jan 16, 2025 03:39PM
Jan 16, 2025 03:38PM Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares i
Jan 13, 2025 09:10AM
Dec 11, 2024 12:51PM
Aug 29, 2024 09:02AM
Aug 29, 2024 09:00AM
Jul 2, 2024 05:16PM
Jun 6, 2024 02:57PM
Jun 6, 2024 02:56PM Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024
Mar 20, 2024 11:01AM
Mar 20, 2024 11:00AM
Mar 5, 2024 09:00AM
Dec 19, 2023 09:00AM
Nov 20, 2023 05:10PM
Nov 6, 2023 04:26PM
Oct 20, 2023 04:21PM Form S-1 Scilex Holding Co
Sep 27, 2023 09:01AM
Sep 27, 2023 09:00AM
Jul 27, 2023 09:00AM
Jul 21, 2023 09:00AM
Jul 21, 2023 09:00AM
Jul 20, 2023 09:01AM
Jul 20, 2023 09:00AM Sorrento Therapeutics, Inc.'s Bankruptcy Court Approves Elective Offering of Restricted Common Stock of Scilex Holding Company for Dividend Short Holders
Jul 19, 2023 06:14AM
Jul 13, 2023 06:02AM
Jun 29, 2023 06:06AM
Jun 20, 2023 06:01AM
Jun 5, 2023 06:08AM
May 23, 2023 06:03AM
Apr 21, 2023 05:22PM Form S-1 Scilex Holding Co
Apr 10, 2023 05:16PM
Jan 12, 2023 04:48PM
Dec 20, 2022 06:09AM
Nov 30, 2022 04:12PM
Nov 30, 2022 04:07PM

66,404 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All